These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 15969661

  • 41. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.
    Schuh S, Dick PT, Stephens D, Hartley M, Khaikin S, Rodrigues L, Coates AL.
    Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819
    [Abstract] [Full Text] [Related]

  • 42. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P.
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [Abstract] [Full Text] [Related]

  • 43. Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study.
    Magnan A, Meunier JP, Saugnac C, Gasteau J, Neukirch F.
    Allergy; 2008 Mar; 63(3):292-8. PubMed ID: 18028246
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis.
    Katial RK, Oppenheimer JJ, Ostrom NK, Mosnaim GS, Yancey SW, Waitkus-Edwards KR, Prillaman BA, Ortega HG.
    Allergy Asthma Proc; 2010 Mar; 31(1):68-75. PubMed ID: 20167147
    [Abstract] [Full Text] [Related]

  • 47. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
    Ostrom NK, Decotiis BA, Lincourt WR, Edwards LD, Hanson KM, Carranza Rosenzweig JR, Crim C.
    J Pediatr; 2005 Aug; 147(2):213-20. PubMed ID: 16126052
    [Abstract] [Full Text] [Related]

  • 48. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG, Rodrigues MT, Zamel N, Chapman KR.
    Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
    [Abstract] [Full Text] [Related]

  • 49. Survey on the impact of comorbid allergic rhinitis in patients with asthma.
    Valovirta E, Pawankar R.
    BMC Pulm Med; 2006 Nov 30; 6 Suppl 1(Suppl 1):S3. PubMed ID: 17140421
    [Abstract] [Full Text] [Related]

  • 50. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N.
    J Asthma; 2007 Nov 30; 44(6):437-41. PubMed ID: 17654129
    [Abstract] [Full Text] [Related]

  • 51. Double-blind, randomised, controlled trial assessing controller medications in asthma.
    Shah AR, Sharples LD, Solanki RN, Shah KV.
    Respiration; 2006 Nov 30; 73(4):449-56. PubMed ID: 16407639
    [Abstract] [Full Text] [Related]

  • 52. Leukotriene receptor antagonists (Montelukast) in the treatment of asthma crisis: preliminary results of a double-blind placebo controlled randomized study.
    Ferreira MB, Santos AS, Pregal AL, Michelena T, Alonso E, de Sousa AV, Pereira E, Palma-Carlos AG.
    Allerg Immunol (Paris); 2001 Oct 30; 33(8):315-8. PubMed ID: 11763721
    [Abstract] [Full Text] [Related]

  • 53. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U, Dass SB.
    Clin Ther; 2008 Oct 30; 30 Spec No():1026-35. PubMed ID: 18640477
    [Abstract] [Full Text] [Related]

  • 54. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.
    Nathan RA, Yancey SW, Waitkus-Edwards K, Prillaman BA, Stauffer JL, Philpot E, Dorinsky PM, Nelson HS.
    Chest; 2005 Oct 30; 128(4):1910-20. PubMed ID: 16236835
    [Abstract] [Full Text] [Related]

  • 55. Randomized trial of a comprehensive asthma education program after an emergency department visit.
    Brown MD, Reeves MJ, Meyerson K, Korzeniewski SJ.
    Ann Allergy Asthma Immunol; 2006 Jul 30; 97(1):44-51. PubMed ID: 16892780
    [Abstract] [Full Text] [Related]

  • 56. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
    Lundbäck B, Rönmark E, Lindberg A, Jonsson AC, Larsson LG, Pétavy F, James M.
    Respir Med; 2006 Jan 30; 100(1):2-10. PubMed ID: 16243498
    [Abstract] [Full Text] [Related]

  • 57. Can montelukast shorten prednisolone therapy in children with mild to moderate acute asthma? A randomized controlled trial.
    Schuh S, Willan AR, Stephens D, Dick PT, Coates A.
    J Pediatr; 2009 Dec 30; 155(6):795-800. PubMed ID: 19656525
    [Abstract] [Full Text] [Related]

  • 58. [Effects of H1 blocker and inhaled corticosteroids on asthmatic patients with allergic rhinitis].
    He WQ, Zheng JP, Ran PX, Liu HZ, Lin H, Cai DM, Xu JM, Zhong NS.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar 30; 26(3):157-60. PubMed ID: 12816681
    [Abstract] [Full Text] [Related]

  • 59. In patients with asthma that is not well controlled with inhaled steroids, does salmeterol (Serevent) or montelukast (Singulair) offer better symptom relief?
    Cash R, Blonski J.
    J Fam Pract; 2001 Sep 30; 50(9):802. PubMed ID: 11674917
    [No Abstract] [Full Text] [Related]

  • 60. Montelukast and airway remodeling in children with chronic persistent asthma: an open study.
    Pifferi M, Caramella D, Ragazzo V, De Marco E, Pietrobelli A, Boner AL.
    Pediatr Allergy Immunol; 2004 Oct 30; 15(5):472-3. PubMed ID: 15482525
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.